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ARTICLE
Intraoperative ultrasonography for presumed 
brain metastases: a case series study
Uso de ultrassonografia intraoperatória para metástases cerebrais presumidas: estudo 
de uma série de casos
Helder Picarelli1, Marcelo de Lima Oliveira2, Edson Bor-Seng-Shu2, Eduardo Santamaria Carvalhal Ribas2, 
Alexandre Maria Santos1, Manoel Jacobsen Teixeira2
Brain metastases (BM) represent more than 50% of intra-
cranial tumors in the adult population and have shown an 
increasing incidence over recent decades1,2. Around 170,000 
patients per year are diagnosed with BM in the United States 
of America. In addition, 10% to 40% of oncologic patients de-
velop BM in the course of the disease1-8. The factors associ-
ated with this increasing incidence include advances in neu-
roimaging techniques, easier access to health care systems, 
and increased survival of cancer patients. The best strategy 
for treating BM remains controversial, but the management 
includes radiotherapy, stereotactic radiosurgery and surgi-
cal resection. Patients are typically treated according to age, 
functional performance, neurological status, type of cancer, 
number and localization of BM, radiosensitivity and chemo-
sensitivity of the tumors, and systemic control of the primary 
cancer5-8. Local control of BM can restore neurological func-
tional status and increase survival of patients that may die 
due to extracranial progression of the disease9-12. Some trials 
suggest that neurosurgical resection is a good option, pre-
senting low recurrence rates especially when followed by ra-
diotherapy6-8,11,12. BM resection can rapidly decrease the mass 
effect and surrounding edema, improve symptoms and qual-
ity of life, control epileptic seizures and provide tissue for 
histological analysis and diagnosis of suspected lesions6-8. 
In addition, resection of multiple BM can also bring positive 
outcomes if systemic cancer is controlled13-15. The objective 
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ABSTRACT
Brain metastases (BM) are one of the most common intracranial tumors and surgical treatment can improve both the functional outcomes 
and patient survival, particularly when systemic disease is controlled. Image-guided BM resection using intraoperative exams, such as in-
traoperative ultrasound (IOUS), can lead to better surgical results. Methods: To evaluate the use of IOUS for BM resection, 20 consecutives 
patients were operated using IOUS to locate tumors, identify their anatomical relationships and surgical cavity after resection. Technical 
difficulties, complications, recurrence and survival rates were noted. Results: IOUS proved effective for locating, determining borders and 
defining the anatomical relationships of BM, as well as to identify incomplete tumor resection. No complications related to IOUS were seen. 
Conclusion: IOUS is a practical supporting method for the resection of BM, but further studies comparing this method with other intraopera-
tive exams are needed to evaluate its actual contribution and reliability.
Key words: intraoperative ultrasound, brain metastases, neurosurgery.
RESUMO
As metástases cerebrais (MC) são os tumores intracranianos mais frequentes e seu tratamento cirúrgico pode melhorar a sobrevida e a 
funcionalidade do paciente, especialmente quando a doença sistêmica está controlada. A ressecção das MC guiada por imagens de exames 
intraoperatórios, como ultrassom intraoperatório (USIO), pode levar a melhores resultados cirúrgicos. Métodos: Avaliar o uso do USIO nas 
ressecções de MC de 20 pacientes para localizar os tumores, avaliar suas relações anatômicas e a cavidade cirúrgica após o procedimento. 
As dificuldades técnicas, complicações, recorrência e taxa de sobrevivência foram anotadas em cada caso. Resultados: USIO foi eficaz para 
localizar, delinear e definir as relações anatômicas das MC, assim como a ocorrência de ressecção incompleta. Não foram encontradas com-
plicações relacionadas ao uso do USIO. Conclusão: USIO é um método auxiliar prático para as ressecções de MC, porém outros estudos ainda 
se fazem necessários para avaliar sua real contribuição nesses procedimentos.
Palavras-Chave: ultrassom intraoperatório, metástases cerebrais, neurocirurgia.
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of surgical treatment is to achieve complete tumor resec-
tion with minimal damage to adjacent structures. The use 
of intraoperative image guidance, such as neuronavigation, 
magnetic resonance imaging (MRI) or ultrasonography (US), 
allows a more accurate detection of BM and reveals their 
anatomical relationships, possibly leading to better surgical 
results16-19. The present study reports a series of twenty pa-
tients with BM in whom intraoperative ultrasound, hence-
forth referred to as IOUS, was used to locate and guide tumor 
resection, as well as to prevent vascular injuries. After the tu-
mor resection, IOUS was performed to identify residual tu-
mor cells, blood clots and foreign bodies in the surgical bed.
The aims of this study were to evaluate the effectiveness 
of IOUS in locating and accurately defining tumors and to 
disclose relationships with adjacent tissues. Additionally, 
the use of IOUS to identify residual tumors, clots and foreign 
bodies in the surgical cavity immediately after tumor resec-
tion was also assessed.
METHODS
Twenty consecutive patients with medical history and/
or lesions in MRI consistent with BM were treated by sur-
gical resection aided by IOUS and followed up prospectively 
for one year. The decision to perform surgical resection was 
taken by a neuro-oncology multidisciplinary group from 
our institution, according to a protocol approved by the lo-
cal Ethics Committee. All patients were given phenytoin 
(300  mg/d), dexamethasone (16 mg/d) and a prophylactic 
antibiotic (cefuroxime) before and during the procedure. The 
patient position during the operation and craniotomy was 
decided according to the tumor location shown by radiologi-
cal exams, MRI (Fig 1), and the surgery was performed using 
classical neurosurgical and stereotactic techniques. Doppler 
ultrasonography was performed immediately after the open-
ing of the dura mater and once again at the end of the surgery 
using a high-resolution system (MicroMax® model, Sonosite®, 
Bothel, WA) with broadband phased array transducers. The 
transducers (6-13 and 4-8 MHz) were protected by sterile 
plastic covers (Fig 1) and saline irrigation was used to im-
prove images. IOUS was first used to determine the tumor 
location and to evaluate its volume, as well as to define its 
borders and relationships with adjacent tissues, and the best 
surgical route to reach the BM (Figs 1–5). After surgery, IOUS 
was used to identify any residual tumor cells, hematomas or 
foreign bodies (Fig 4A). Technical difficulties, duration of the 
surgery, time required to locate the lesions by IOUS, and sur-
gical complications during or after the surgery were all noted.
The accuracy of IOUS for locating tumors was compared 
to that of stereotactic localization by Aimsystem® Stereotactic 
System (Micromar®). The lesions’ volume estimated by IOUS 
were compared to the estimates based on the preopera-
tive MRI using the formula V = π/6xAxBxC (where A, C and 
Fig 1. Case 2: Cavernoma. (A) Magnetic Resonance Images, (B) 
Intraoperative ultrasound, (C) IOUS Images of subcortical and 
hypoechoic tumor, (D) Tumor was resected em bloc.
A
C
B
D
D correspond to the largest tumor diameter on sagittal, cor-
onal and axial views). The presence of residual tumor cells 
in  the  surgical cavity was assessed by IOUS after the resec-
tion; the imaging was later on compared to the brain CT-scan 
Fig 2. Case 10: Glioblastoma Multiforme. (A) Contrast 
enhanced T1 MRI image; (B) IOUS showing middle cerebral 
artery branch within tumor.
B
A
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Fig 4. Brain metastasis of breast cancer. (A) IOUS image after 
the lesion resection discloses another small tumor below the 
surgical cavity, not seen under the microscope.
Fig 5. Case 4: Brain metastasis of melanoma. Merged IOUS 
and MRI images: the IOUS oriented the corticectomy and 
the best route to approach the tumor through the insula. 
Images clearly show ventricles, midline shift, tumor and 
relationships with middle artery branches. This patient had 
a good neurological recovery immediately after the surgery 
with no motor deficit and he’s submitted to radiotherapy. Two 
hundread and thirty days later he died of gastrointestinal 
bleeding secondary to bowel metastases and meningeal 
carcinomatosis. There was not local recurrence.
images, performed in all cases within 24 hours postopera-
tively. Differences between tumor volumes calculated using 
IOUS compared to preoperative MRI greater than or equal to 
5% were considered discordant predicted volumes (p-value). 
Contrast-enhancing brain lesions on the postoperative CT-
scan were regarded as probable residual tumor cells and con-
sidered discordant if IOUS did not detect the same finding. The 
suspected areas identified by IOUS were biopsied and sent to 
the laboratory for anatomopathological examination. All pa-
tients received the same radiotherapy irradiation dose to the 
surgical site given within the first five weeks of surgery.
RESULTS
Patients’ mean age was 53.4 years (26–76 years), twelve of 
them were males (60%), and three (15%) had no previous on-
cological history. Twenty-three BM were operated in the study 
(Table 1). Histological analysis confirmed BM in 85% of the pa-
tients. Two of them were diagnosed with glioblastoma multi-
forme and one with cavernoma (Fig 1 and Table 2). In all cas-
es, IOUS indicated the tumor localization in the first minute of 
the exam, and the results were in agreement with stereotactic 
localization. In all cases, ultrasonographic characterization of 
the lesions was in agreement with the preoperative MRI find-
ings in terms of tumor borders and anatomical relationships to 
ventricular and vascular structures. The volume of the lesion 
was calculated based on intraoperative US images in five pa-
tients, and a significant correspondence to the volume calcu-
lated from the preoperative MRI was observed in all cases. Six 
lesions (26.1%) were superficial, at the cortex, being identified 
by direct visualization; IOUS was then used to determine the 
echographic characteristics and anatomical relationships, and 
to search for residual tumor cells after resection. Seventeen 
lesions were subcortical, and intraoperative US was used in 
these cases to guide the surgeon in electing the best route to 
reach the lesion (Figs 4 and 5).
In eleven cases (55%), IOUS identified suspected areas of 
residual tumor cells at the surgical bed, eight of which (72.7%) 
were later confirmed by anatomopathological examination 
(Fig 4A). The three remaining suspected lesions were diag-
nosed as gliosis, necrosis and thermal lesion. No contrast-en-
hancing lesions supposedly missed by IOUS were identified 
in the postoperative CT-scan.
Doppler color flow imaging mode revealed important re-
lations between the vascular structures and the tumor in five 
cases (25%), but accidental vascular injuries were not found. In 
four cases (20%), the surgical strategy was modified based on 
Fig 3. Case 5: Thalamic Brain Metastasis of colon 
adenocarcinoma. (A) Contrast enhanced T1 MRI image, (B) 
IOUS showing corticectomy and optimal route to reach tumor, 
(C) Intraoperative view.
C
A
B
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Table 2. Surgical findings, IOUS image characteristics, and postoperative evolution.
PE: perilesional edema, WD: well-delimited, WOVR: without important vascular relations, MCA: middle cerebral artery, LV: lateral ventricle, R: resection, IOUS: 
intraoperative ultrasound, RT: residual tumor, IDC: breast invasive ductal carcinoma.
Case Anatomopathological diagnosis IOUS findings
Complete R 
(IOUS)
Complete R 
(CT-scan) Recurrence
1 Metastatic carcinoma Solid and hyperechoic lesion, WD, PE, WOVR Yes Yes No
2 Cavernoma Cystic and hypoechoic lesion, WD, small PE, WORV Yes Yes No
3 Osteosarcoma Cystic and hypoechoic lesion, WD, small PE, WORV, RT Yes Yes No
4 Melanoma Solid-cystic and heterogenous lesion, WD, MCA relation, RT No No Yes
5 Colon Adenocarcinoma Solid and hyperechoic lesion, WD, PE, WOVR, LV relation, RT Yes Yes Yes
6 Colon Adenocarcinoma Solid and hyperechoic lesion, WD, PE, WOVR, LV relation, RT Yes Yes No
7 Lung carcinoma Solid-cystic and heterogenous lesion, WD, torcula relation, RT Yes Yes No
8 Lung carcinoma Solid-cystic and predominately hyperechoic lesion, WD, WOVR, RT Yes Yes No
9 Urinary bladder carcinoma Solid and hyperechoic lesion, WD, PE, WOVR, RT Yes Yes No
10 Glioblastoma multiforme Heterogenous lesions, WD, MCA relation, RT Yes Yes No
11 Melanoma Solid-cystic and hyperechoic lesion, WOVR Yes Yes No
12 Glioblastoma multiforme Solid and heterogenous lesion, WD, WOVR No No Yes
13 Breast IDC Solid and hyperechoic lesion, WD, WOVR, RT Yes Yes No
14 Lung adenocarcinoma Cystic and hypoechoic lesion with hyperechoic nodule, WD, WORV, RT Yes Yes No
15 Breast IDC Solid lesion with central cystic area, predominantly hyperechoic, WD, WOVR, RT Yes Yes No
16 Melanoma Solid and hyperchoic lesion, WD, WOVR Yes Yes Yes
17 Urinary bladder carcinoma Solid and hyperchoic lesion, WD, WOVR Yes Yes No
18 Lung adenocarcinoma Cystic and hypoechoic lesion, WD, small PE, WORV Yes Yes No
19 Breast IDC Cystic and hypoechoic lesion, WD, WORV Yes Yes No
20 Melanoma Cystic and hyperechoic lesion, WD, WORV Yes Yes No
Table 1. Patients and data.
C: cortical, SC: subcortical, D: deep, ASA: American Society of Anesthesiologists classification, ECOG: Eastern Cooperative Oncology Group performance status, 
SIR: Score Index for Radiosurgery of brain metastases, KPS: Karnofsky Performance Scale.
*Volume: π/6xAxBxC, where A, B and C correspond to the lesion’s largest diameter on axial, coronal and sagittal MRI images.
Case Age (years) Oncological history
N° of Lesions/ 
volume (cc3)* Localization ASA ECOG SIR KPS
1 42 Breast Invasive ductal carcinoma 2/ 6.56 C-SC, occipital II 1 6 80
2 57 Lymphoma 1/ 3.81 precentral gyrus III 4 7 40
3 26 Osteosarcoma 1/ 77.71 C-SC-P, frontal lobe III 1 6 80
4 45 Melanoma 1/ 17.08 D, insula III 1 4 90
5 61 Colon adenocarcinoma 1/ 15.5 D, thalamus II 2 3 80
6 41 Colon adenocarcinoma 1/ 13.13 D, parieto-occipital II 1 6 70
7 76 X 1/ 14.97 C-SC, parieto-occipital III 2 2 40
8 70 X 1/ 7.24 C-SC, parietal III 3 3 50
9 52 Clear cell renal carcinoma 3/ 1.98 C-SC, occipital III 3 3 50
10 70 Prostate adenocarcinoma 1/ 22.08 D, frontal III 1 6 90
11 34 Melanoma 1/ 3.04 C-SC, frontal I 1 7 90
12 49 X 1/31.34 C-SC-D, parieto-occipito-temporal II 1 7 80
13 67 Breast Invasive ductal carcinoma 1/ 8.05 D, cerebellum II 1 5 90
14 65 Lung adenocarcinoma 1/2.84 C, frontal II 3 3 40
15 64 Breast Invasive ductal carcinoma 1/9.97 C-SC, frontal III 2 6 80
16 26 Melanoma 1/12.23 D, temporal II 1 7 90
17 72 Urinary bladder carcinoma 1/56.16 C-SC, frontal III 4 2 30
18 63 Lung adenocarcinoma 1/23.47 D, parieto-occipital III 3 2 50
19 42 Breast Invasive ductal carcinoma 1/ 3.78 SC, frontal III 1 6 90
20 47 Melanoma 1/18.14 D, cerebellum II 1 6 70
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IOUS findings, which revealed an alternative route for the neu-
rosurgeon to reach the lesion and perform the resection (Fig 4). 
Mean total operation time for a single lesion was 289 minutes 
and total usage of IOUS never exceeded thirty minutes.
There were no complications related to the surgical proce-
dure per se, such as neurological worsening, wound infections, 
meningitis, abscess, contusions or hematomas. Patient survival 
time ranged from fifteen days (death related to sepsis and central 
venous access infection) to 365 days (maximum follow-up time). 
Functional performance improved after surgery in thirteen pa-
tients (65%), and was unchanged in six of them. The most rel-
evant surgical and follow-up findings are shown in Table 2.
Survival rates in the first, second and third months were 
95%, 95% and 80%, respectively. Mean follow-up time was 180 
days (15 to 365 days), and three patients presented with local 
tumor recurrence after BM resection. All recurrences were 
related to meningeal carcinomatosis (2 patients with mela-
noma and 1 patient with colon adenocarcinoma) (Fig 3), and 
these patients died during follow-up.
DISCUSSION
Brain metastases are more common than primary brain 
cancer and there is debate over the best treatment protocol. 
Well-designed studies conducted with patients with single 
BM, good functional performance, and controlled system-
ic cancer suggest that neurosurgery is an effective option for 
local disease control14,15. BM happens by expansion and can 
reach a significant volume, increasing intracranial pressure 
and promoting inflammation in adjacent tissues and brain 
vasogenic edema. The complete resection of BM can resolve 
some of these processes, restoring neurological functions and 
solving symptoms. Additionally, surgery allows confirmation 
of the histological diagnosis of the tumor. In our series, BM was 
confirmed in 85% of the patients, which enabled their referral, 
as well as the 15% non-confirmed cases, to appropriate treat-
ment. Although surgery are very beneficial for patients, the de-
cision should always be made by weighing up the benefits and 
risks. The surgical morbidity and mortality associated to the 
procedure are estimated to be less than 3 and 5%, respective-
ly. The most common complications are neurological worsen-
ing, wound infections, intracranial hematomas, deep venous 
thrombosis, pulmonary embolism and pneumonia.
The extension of tumor resection is an important fac-
tor when it comes to decreasing the local tumor progression 
rate and increasing patient survival. Complete tumor resec-
tion is possible provided that the lesion borders are well de-
fined, the tumor is removed en bloc, and potential residual 
cells are recognized during surgery. Intraoperative radiolog-
ical exams such as MRI or IOUS may promptly identify le-
sion borders, anatomical relationships and residual tumor 
cells with high sensitivity, leading to more complete and safe 
tumor removal16-19. The choice of the method also depends 
on their availability and on the neurosurgeon’s personal expe-
rience. Intraoperative MRI provides high-quality images, but 
is still an expensive option that is rarely available in Brazil. 
The technique also requires complex infrastructure, and im-
age acquisition time is longer. Lower cost, more practical us-
age, ability to repeat the exam several times and faster image 
acquisition are some of the characteristics that make IOUS 
a more attractive method of choice. All lesions in our series 
were located in less than one minute using this method, and 
their size, shape, borders, anatomical relations, as well as 
identification of necrosis, edema and calcifications were de-
termined in most cases and proved concordant with preop-
erative exam findings. IOUS also indicated where it was best 
to open the dura-mater, the direction and relationships of 
each sulcus with the tumor, the optimal point to perform the 
corticectomy, and the best route to approach the tumor. The 
use of Doppler color flow helped identify important vascular 
structures, preventing possible injuries.
In this study, all tumors were promptly located by IOUS, 
irrespective of their location. Solid and hypercellular lesions 
appeared as hyperechoic, homogenous and well-defined im-
ages. Hemorrhagic areas and necrosis, detected within some 
lesions, appeared as hypoechoic images. Small calcifications 
were not identified by IOUS, but large calcifications were in-
directly detected by its acoustic shadow. Cystic lesions were 
seen as hypoechoic images. Cotton, Surgical and organized 
hematomas were identified as hyperechoic images, thus en-
abling later removal. Before tumor resection, we found no dif-
ficulties in differentiating the tumor from normal brain tis-
sue. However, it was difficult to differentiate residual tumor 
cells, gliosis and contusions after resection. Our data suggest 
that IOUS has high sensitivity but low specificity when used 
for this purpose. At the end of the procedure, the surgical cav-
ity was filled with 0.9% saline solution and appeared as a hy-
poechoic area surrounded by normal brain tissue (Fig 4A). 
The extension of tumor removal using postoperative MRI 
(gold-standard) was not evaluated in the present investiga-
tion and future studies are needed to compare both methods.
IOUS was used with 6-13 MHz and 4–8 MHz transduc-
ers. Better image quality was achieved with the 6–13 MHz 
transducer, but allowed only superficial (up to 4 cm from 
the cortex) lesions to be visualized. Deeper (2.5 to 6 cm 
from the cortex) lesions were better visualized using the 
4-8 MHz transducer. Volume calculation was possible if le-
sions were small and if their axis could be seen in one single 
image. Because of the small contact area of the transducer 
to the brain, the volume was measurable only in only 5 cas-
es (25%). Dislocation of cerebral structures, a phenomenon 
known as “brain shift” that occurs during the procedure and 
interferes with the correct localization of surgical targets 
when based on preoperative radiological exams, did not af-
fect the accuracy of IOUS18,19.
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Incorrect patient positioning or craniotomy procedures, a 
poor quality IOUS device and little experience of the surgeon 
with the method can decrease the effectiveness of the exam. 
However, the skill needed to use this harmless and effective 
intraoperative guidance tool can be easily acquired with a lit-
tle dedication. Recent studies have demonstrated that three-
dimensional IOUS images can be used in conjunction with 
other intraoperative guidance methods, but further studies 
are needed to evaluate their advantages.
In conclusion, IOUS constitute a practical, accurate, fast 
and safe method for guiding BM resections. Tumor lesion iden-
tification was made independently of their location or histology. 
Surgical procedures were oriented by IOUS, which indicated the 
optimal route to approach the lesions, as well as important an-
atomical relationships, and residual tumor cells. There was no 
significant increase in the total surgery time or in complications 
related to this method. We recommend that all neurosurgeons 
striving for safer and accurate procedures undergo IOUS training.
